{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T22:17:40Z","timestamp":1783117060949,"version":"3.54.6"},"reference-count":26,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T00:00:00Z","timestamp":1690761600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014035","name":"AFHSB","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004238","name":"Universit\u00e4t Potsdam","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004238","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019734","name":"Kenya Medical Research Institute","doi-asserted-by":"publisher","award":["L-183"],"award-info":[{"award-number":["L-183"]}],"id":[{"id":"10.13039\/501100019734","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.heliyon.2023.e18863","type":"journal-article","created":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T21:26:10Z","timestamp":1690838770000},"page":"e18863","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Ex vivo and In vitro antiplasmodial activities of approved drugs predicted to have antimalarial activities using chemogenomics and drug repositioning approach"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7406-7492","authenticated-orcid":false,"given":"Douglas O.","family":"Ochora","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6454-1613","authenticated-orcid":false,"given":"Reagan M.","family":"Mogire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8171-3605","authenticated-orcid":false,"given":"Rael J.","family":"Masai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Redemptah A.","family":"Yeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1193-1989","authenticated-orcid":false,"given":"Edwin W.","family":"Mwakio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1536-968X","authenticated-orcid":false,"given":"Joseph G.","family":"Amwoma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6938-1150","authenticated-orcid":false,"given":"Dancan M.","family":"Wakoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1123-3200","authenticated-orcid":false,"given":"Abiy","family":"Yenesew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8584-2706","authenticated-orcid":false,"given":"Hoseah M.","family":"Akala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2023.e18863_bib1","series-title":"Malaria Report","year":"2021"},{"key":"10.1016\/j.heliyon.2023.e18863_bib2","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S1473-3099(17)30048-8","article-title":"The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion: a molecular epidemiology observational study","volume":"17","author":"Imwong","year":"2017","journal-title":"Lancet Infectious Diseases"},{"key":"10.1016\/j.heliyon.2023.e18863_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/cshperspect.a025619","article-title":"Antimalarial drug resistance: a threat to malaria elimination","volume":"7","author":"Menard","year":"2017","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.heliyon.2023.e18863_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12936-020-03407-1","article-title":"History of malaria control in Rwanda : implications for future elimination in Rwanda and other malaria - endemic countries","volume":"19","author":"Karema","year":"2020","journal-title":"Malaria Journal"},{"key":"10.1016\/j.heliyon.2023.e18863_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules21050559","article-title":"The traditional medicine and modern medicine from natural products","volume":"21","author":"Yuan","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.heliyon.2023.e18863_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2875-10-20","article-title":"Anti-malarial activity of Holarrhena antidysenterica and Viola canescens, plants traditionally used against malaria in the Garhwal region of north-west Himalaya","volume":"10","author":"Verma","year":"2011","journal-title":"Malaria Journal"},{"key":"10.1016\/j.heliyon.2023.e18863_bib7","doi-asserted-by":"crossref","first-page":"64","DOI":"10.4103\/0975-7406.67002","article-title":"Structural modifications of quinoline-based antimalarial agents: recen developments","volume":"2","author":"Bawa","year":"2010","journal-title":"J. Pharm. Bioallied Sci."},{"key":"10.1016\/j.heliyon.2023.e18863_bib8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.5530\/srp.2017.1.4","article-title":"Plant Flavonoids as Potential source of Future Antimalarial leads","volume":"8","author":"Rudrapal","year":"2017","journal-title":"Systematic Review Pharmacology"},{"key":"10.1016\/j.heliyon.2023.e18863_bib9","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.healthpol.2010.12.002","article-title":"The cost of drug development: A systematic review","volume":"100","author":"Morgan","year":"2011","journal-title":"Health Policy"},{"key":"10.1016\/j.heliyon.2023.e18863_bib10","doi-asserted-by":"crossref","first-page":"60","DOI":"10.30750\/ijpbr.1.2.11","article-title":"In-Silico Drug Design: A revolutionary approach to change the concept of current Drug Discovery Process","volume":"1","author":"Boruah","year":"2013","journal-title":"Indian J. Pharmaceut. Biol. Res."},{"key":"10.1016\/j.heliyon.2023.e18863_bib11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2174\/156802610790232251","article-title":"Successful applications of Computer aided Drug Discovery : moving Drugs from Concept to the Clinic","volume":"10","author":"Talele","year":"2010","journal-title":"Current Topics in Medicinal Chemistry"},{"key":"10.1016\/j.heliyon.2023.e18863_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/annotation\/0bbd3579-5212-4dcf-a5ef-dd3d8e26f287","article-title":"Systematic In silico Search for Target Similarity Identifies several Approved Drugs with Potential Activity against the Plasmodium falciparum Apicoplast","volume":"8","author":"Bispo","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.heliyon.2023.e18863_bib13","first-page":"1","article-title":"Silico Repositioning-Chemogenomics Strategy Identifies New Drugs with Potential Activity against multiple Life stages of Schistosoma mansoni","volume":"9","author":"Neves","year":"2015","journal-title":"Neglected Tropical Diseases"},{"key":"10.1016\/j.heliyon.2023.e18863_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ph11010015","article-title":"Drug repurposing for schistosomiasis : combinations of Drugs or biomolecules","volume":"11","author":"Gouveia","year":"2018","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.heliyon.2023.e18863_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0186364","article-title":"Target-similarity search using Plasmodium falciparum proteome identifies approved drugs with anti-malarial activity and their possible targets","volume":"12","author":"Mogire","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2023.e18863_bib16","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1186\/1475-2875-9-375","article-title":"Implementation of a reference standard and proficiency testing programme by the World Wide Antimalarial Resistance Network (WWARN)","volume":"9","author":"Lourens","year":"2010","journal-title":"Malaria Journal"},{"key":"10.1016\/j.heliyon.2023.e18863_bib17","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1126\/science.781840","article-title":"Human malaria parasites in continuous culture","volume":"20","author":"Trager","year":"1976","journal-title":"Science"},{"key":"10.1016\/j.heliyon.2023.e18863_bib18","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1186\/s12916-022-02652-2","article-title":"Impact of parasite genomic dynamics on the sensitivity of Plasmodium falciparum isolates to piperaquine and other antimalarial drugs","volume":"20","author":"Wakoli","year":"2022","journal-title":"BMC Med"},{"key":"10.1016\/j.heliyon.2023.e18863_bib19","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.actatropica.2012.04.011","article-title":"The antiplasmodial and radical scavenging activities of flavonoids of Erythrina burttii","volume":"123","author":"Yenesew","year":"2012","journal-title":"Acta Tropica"},{"key":"10.1016\/j.heliyon.2023.e18863_bib20","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1128\/AAC.00527-15","article-title":"Assessment of the Worldwide antimalarial resistance network standardized procedure for in vitro malaria drug sensitivity testing using SYBR green assay for field samples with various initial parasitemia levels","volume":"60","author":"Cheruiyot","year":"2016","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.heliyon.2023.e18863_bib21","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4269\/ajtmh.2011.10-0674","article-title":"Antimalarial Drug Sensitivity profile of western Kenya Plasmodium falciparum Field Isolates Determined by a SYBR Green I in vitro Assay and Molecular Analysis","volume":"85","author":"Akala","year":"2011","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"key":"10.1016\/j.heliyon.2023.e18863_bib22","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.3390\/molecules14083037","article-title":"Plant-derived antimalarial agents: New leads and efficient phytomedicines. part II. non-alkaloidal natural products","volume":"14","author":"Batista","year":"2009","journal-title":"Molecules"},{"key":"10.1016\/j.heliyon.2023.e18863_bib24","first-page":"1","article-title":"Computational Chemogenomics Drug Repositioning Strategy enables the Discovery of Epirubicin as a New repurposed hit","volume":"64","author":"Ferreira","year":"2020","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.heliyon.2023.e18863_bib25","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0022-2836(05)80360-2","article-title":"Basic local alignment search tool","volume":"215","author":"Altschul","year":"1990","journal-title":"Journal of Molecular Biology"},{"key":"10.1016\/j.heliyon.2023.e18863_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrd2275","article-title":"Determining druggability Druggability","volume":"6","author":"Owens","year":"2007","journal-title":"Nature Reviews Drug Discovery"},{"key":"10.1016\/j.heliyon.2023.e18863_bib27","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1093\/nar\/gkr1053","article-title":"TDR Targets : a chemogenomics resource for neglected diseases","volume":"40","author":"Magarinos","year":"2012","journal-title":"Nucleic Acids Research"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023060711?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023060711?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T21:30:31Z","timestamp":1783114231000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844023060711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S2405844023060711"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e18863","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ex vivo and In vitro antiplasmodial activities of approved drugs predicted to have antimalarial activities using chemogenomics and drug repositioning approach","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e18863","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e18863"}}